Oligosaccharide configuration of fibrinogen Kaiserslautern: Electrospray ionisation analysis of intact γ chains

Thrombosis and Haemostasis

Volumn 80, Issue 2, 1998, Pages 263-265

  Brennan, Stephen O ^a   Loreth, Ralph M ^b   George, Peter M ^a  

^a CANTERBURY HEALTH LABORATORIES   (New Zealand)

^b Westpfalz Klinikum GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; N ACETYL BETA GLUCOSAMINIDASE; OLIGOSACCHARIDE; SIALIC ACID; SIALIDASE;

ARTICLE; CONTROLLED STUDY; COVALENT BOND; HUMAN; HYDROLYSIS; MASS SPECTROMETRY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; SIALYLATION; X RAY ANALYSIS;

EID: 0031849269     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615185     Document Type: Article

References (17)

1. Henschen A, McDonagh J. Fibrinogen, fibrin and factor XIII. In: Blood Coagulation. Zwaal FFA, Hemker HC, eds. Elsevier Science Publishers BV Amsterdam 1986; pp 171-241.
2. Doolittle RF. The molecular biology of fibrin. In: The Molecular Basis of Blood Diseases. Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H, eds. WB Saunders Company Philadelphia 1994; pp 701-23.
3. Dang CV, Shin CK, Bell WR, Nagaswami C, Weisel JW. Fibrinogen sialic acid residues are low affinity calcium binding sites that influence fibrin assembly. J Biol Chem 1989; 264: 15104-8.
4. Martinez J, Palascak J, Peters C. Functional and metabolic properties of human asialo fibrinogen. J Lab Clin Med 1977; 89: 367-77.
5. Langer BC, Weisel JW, Dinauer PA, Nagaswami C, Bell WR. Deglycosylation of fibrinogen accelerates polymerisation and increases lateral aggregation of fibrin fibers. J Biol Chem 1988; 263: 15056-63.
6. Ridgway HJ, Brennan SO, Loreth RM, George PM. Fibrinogen Kaiserslautern (γ 380 Lys to Asn) a new glycosylated variant with delayed polymerisation. Brit J Haematol 1997; 99: 562-9.
7. Brennan SO. Electrospray ionisation analysis of human fibrinogen. Thromb Haemost 1997; 78: 1055-8.
8. Brennan SO, Myles T, Peach R, Donaldson D, George PM. Albumin Redhill (-1 Arg, 320 Ala→Thr) a glycoprotein variant of human albumin whose precursor has an aberrant signal peptide cleavage site. Proc Natl Acad Sci USA 1990; 87: 26-30.
9. Brennan SO, Hammonds B, Spearing R, George PM. Electrospray ionisation mass spectrometry facilitates detection of fibrinogen (Bβ 14 Arg→Cys) mutation in a family with thrombosis. Thromb Haemost 1997; 78: 1484-7.
10. Townsend RR, Hilliker E, Li Y-T, Laine RA, Bell WR, Lee YC. Carbohydrate structure of human fibrinogen. J Biol Chem 1982; 257: 9704-10.
11. Townsend RR, Heller DN, Fenselau CC, Lee YC. Determination of the sialylation pattern of human fibrinogen glycopeptides with fast atom bombardment. Biochemistry 1984: 23; 6389-92.
12. Martinez J, MacDonald KA, Palascak JE. The role of sialic acid in the dysfibrinogemia associated with liver disease: distribution of sialic acid on constituent chains. Blood 1983; 61: 1196-202.
13. Maekawa H, Yamazumi K, Muramatsu S, Kaneko M, Hirata H, Takahashi N, Arocha-Pinango CL, Rodriguez S, Nagy H, Perez-Rrequejo JL, Matsuda M. Fibrinogen Lima: a homozygous dysfibrinogen with an Aα Arg-141 to Ser substitution associated with extra N-Glycosylation at Asn-139. J Clin Invest 1992; 90: 67-76.
14. Yamazumi K, Simura K, Terukina S, Takahashi N, Matsuda M. A γ Met 310 to Thr substitution and consequent N-glycosylation at γ Asn-308 identified in a congenital dysfibrinogenemia associated with posttraumatic bleeding, fibrinogen Asahi. J Clin Invest 1989; 83: 1590-7.
15. Matsuda M. The steucture function relationship of hereditary dysfibrinogens. Int J Haematol 1996; 64: 167-79.
16. Spraggon G, Everse SJ, Doolittle RF. Crystal structures of fragment D from human fibrinogen and its counterpart from fibrin. Nature 1997; 389: 455-62.
17. Mosesson M, Siebenlist KR, DiOrio JP, Matsudo M, Hainfeld JF, Wall JS. The role of fibrinogen D domain intermolecular association sites in the polymerisation of fibrin and fibrinogen Tokyo II (γ275 Arg→Cys). J Clin Invest 1995; 96: 1053-8.